Skip to main content
< Back
About
About the conference
Organisers & Partners
Registration
App
Podcast
Early Career Researchers
Call for abstracts
Guidelines
Latest updates
Press room
Venue
About the venue
Rooms
Programme
Full programme
Programme outline
Tracks
Speakers
All speakers
Keynote speakers
Side events
Subscribe
days
hours
minutes
seconds
Oral presentation session
Sessions
PDF version
Wednesday, 23 October
10:50
Advances in drug treatment
10:50
to
12:20
Auditorium II
Oral presentation session
Innovative health approaches
10:50
to
12:20
Auditorium III
Oral presentation session
Sex, gender and diversity in drugs
10:50
to
12:20
Auditorium IV
Oral presentation session
Advancing addiction research: global perspectives and collaborative initiatives
10:50
to
12:20
Auditorium VI
Oral presentation session
Lives at risk: mental health and substance use
10:50
to
12:20
Auditorium VII
Oral presentation session
Prevalence of opioids and related harms
10:50
to
12:20
Auditorium VIII
Oral presentation session
Mechanisms and outcomes in substance use prevention among youth
10:50
to
12:20
Room 5A
Oral presentation session
Gambling: work-related, financial, and criminological issues
10:50
to
12:20
Room 5B
Oral presentation session
Building addiction workforce capacity
10:50
to
12:20
Room 5C
Oral presentation session
13:20
Alcohol use in the young
13:20
to
14:50
Auditorium II
Oral presentation session
Legal shifts and their Impact on drug use and sentencing
13:20
to
14:50
Auditorium IV
Oral presentation session
Drug policy and the criminal legal system
13:20
to
14:50
Auditorium VI
Oral presentation session
Tobacco, mental health and other substance use
13:20
to
14:50
Auditorium VII
Oral presentation session
Gender and substance use
13:20
to
14:50
Auditorium VIII
Oral presentation session
Substance use interventions in youth
13:20
to
14:50
Room 5A
Oral presentation session
Neurocognitive processes in behavioural addictions
13:20
to
14:50
Room 5B
Oral presentation session
Learning from Africa: workforce development, enhancement and support
13:20
to
14:50
Room 5C
Oral presentation session
Challenge of measuring use and impact of cannabinoids
13:20
to
14:50
Room 1.07
Oral presentation session
15:00
Alcohol use from brief intervention to harm reduction
15:00
to
16:30
Auditorium II
Oral presentation session
The recovery journey
15:00
to
16:30
Auditorium III
Oral presentation session
Infectious diseases in people who inject drugs
15:00
to
16:30
Auditorium IV
Oral presentation session
Measuring drug market phenomenon
15:00
to
16:30
Auditorium VI
Oral presentation session
Substance use and psychosis
15:00
to
16:30
Auditorium VII
Oral presentation session
The growing threat of synthetic drugs – developments and responses in North America and Europe
15:00
to
16:30
Auditorium VIII
Oral presentation session
Surveillance of drug-related morbidity and mortality
15:00
to
16:30
Room 5A
Oral presentation session
Assessment of behavioural addictions
15:00
to
16:30
Room 5B
Oral presentation session
Inequalities and needs of migrant groups
15:00
to
16:30
Room 5C
Oral presentation session
Quality in addictions work systems
15:00
to
16:30
Room 1.06
Oral presentation session
16:50
Strengthening quality in substance use disorders treatment
16:50
to
18:20
Auditorium II
Oral presentation session
NPS: trends, concerns and response strategies
16:50
to
18:20
Auditorium III
Oral presentation session
Drug use trends
16:50
to
18:20
Auditorium IV
Oral presentation session
Decriminalisation and alternatives to arrest
16:50
to
18:20
Auditorium VI
Oral presentation session
Understanding interrelationships: mental health and substance use
16:50
to
18:20
Auditorium VII
Oral presentation session
Psychedelics 1
16:50
to
18:20
Auditorium VIII
Oral presentation session
Novel and contextual approaches in prevention
16:50
to
18:20
Room 5A
Oral presentation session
Opioid treatment 1
16:50
to
18:20
Room 5B
Oral presentation session
Motivations for use
16:50
to
18:20
Room 5C
Oral presentation session
Thursday, 24 October
10:50
Predicting the future: biomarkers for progression of alcohol use disorder
10:50
to
12:20
Auditorium II
Oral presentation session
Opioid treatment 2
10:50
to
12:20
Auditorium III
Oral presentation session
Opioid Agonist Treatment: novel formulations and challenges
10:50
to
12:20
Auditorium IV
Oral presentation session
Evidence informed drug and alcohol policy
10:50
to
12:20
Auditorium VI
Oral presentation session
Innovative methods for understanding drug markets and policy
10:50
to
12:20
Room 5A
Oral presentation session
Workers reaching marginalised groups
10:50
to
12:20
Room 5C
Oral presentation session
Challenges, threats, and opportunities in addiction publishing today
10:50
to
12:20
Room 1.05
Oral presentation session
Contemporary issues
10:50
to
12:20
Room 1.08
Oral presentation session
13:20
Novel neurobiology - cannabis, cognition and craving
13:20
to
14:50
Auditorium III
Oral presentation session
Understanding drug-related deaths
13:20
to
14:50
Auditorium IV
Oral presentation session
Conceptual frameworks for studying drug policy
13:20
to
14:50
Auditorium VI
Oral presentation session
Young people, mental health and substance use
13:20
to
14:50
Auditorium VII
Oral presentation session
Nitazene-related fatal and non-fatal toxicity in Europe: hospital emergency perspective
13:20
to
14:50
Auditorium VIII
Oral presentation session
Public health and safety impacts of cannabis legalization in Canada: five years in review
13:20
to
14:50
Room 5A
Oral presentation session
Pregnancy, drug use and care
13:20
to
14:50
Room 5B
Oral presentation session
Co-creating robust systems with workers
13:20
to
14:50
Room 5C
Oral presentation session
Women's realities of drug use
13:20
to
14:50
Room 1.08
Oral presentation session
15:00
Alcohol epidemiology: social inequalities
15:00
to
16:30
Auditorium II
Oral presentation session
NPS: Pharmacological Characterization and Substance Analysis
15:00
to
16:30
Auditorium III
Oral presentation session
Hepatitis C testing and treatment
15:00
to
16:30
Auditorium IV
Oral presentation session
Cannabis legalisation — models and impacts
15:00
to
16:30
Auditorium VI
Oral presentation session
How can treatment be a better experience?
15:00
to
16:30
Auditorium VII
Oral presentation session
Protective and risk factors in drug prevention
15:00
to
16:30
Room 5A
Oral presentation session
Policy issues in gambling
15:00
to
16:30
Room 5B
Oral presentation session
A unique care model for inpatient addictions and tri-morbidity within an acute UK hospital
15:00
to
16:30
Room 5C
Oral presentation session
Novel psychoactive substances and latest drug trends in Asia and Pacific countries
15:00
to
16:30
Room 1.05
Oral presentation session
Drug trends: experiences from Brazil, the Netherlands, Portugal, and Spain
15:00
to
16:30
Room 1.08
Oral presentation session
16:50
Alcohol and gender issues
16:50
to
18:20
Auditorium II
Oral presentation session
Mixed methods for understanding drug use
16:50
to
18:20
Auditorium III
Oral presentation session
Viral hepatitis among people who inject drugs
16:50
to
18:20
Auditorium IV
Oral presentation session
Alcohol use among the elderly
16:50
to
18:20
Auditorium VI
Oral presentation session
Substance use and mental health in treatment settings
16:50
to
18:20
Auditorium VII
Oral presentation session
Misuse of medicines
16:50
to
18:20
Auditorium VIII
Oral presentation session
New research on alcohol and tobacco policy
16:50
to
18:20
Room 5A
Oral presentation session
Hospital-based treatments
16:50
to
18:20
Room 5B
Oral presentation session
From old to new: changes in drug use
16:50
to
18:20
Room 5C
Oral presentation session
ScaleUp: Options for scalable psychosocial and pharmacological treatment of stimulant use disorder
16:50
to
18:20
Room 1.08
Oral presentation session
Friday, 25 October
10:50
Alcohol: interventions and up-to-date technologies
10:50
to
12:20
Auditorium II
Oral presentation session
Gaming and social media use
10:50
to
12:20
Auditorium III
Oral presentation session
Intentional and non-intentional drug-related deaths
10:50
to
12:20
Auditorium IV
Oral presentation session
Psychedelics 2
10:50
to
12:20
Auditorium VI
Oral presentation session
Trauma and substance use
10:50
to
12:20
Auditorium VII
Oral presentation session
Unravelling the nexus: understanding drug-related violence across Europe
10:50
to
12:20
Auditorium VIII
Oral presentation session
Drugs checking services
10:50
to
12:20
Room 5A
Oral presentation session
Online monitoring
10:50
to
12:20
Room 5B
Oral presentation session
Substance use and treatment needs across European prisons
10:50
to
12:20
Room 5C
Oral presentation session
Support for the addiction workforce
10:50
to
12:20
Room 1.07
Oral presentation session
13:20
Findings from The Lancet Public Health Commission on Gambling: protecting the public from gambling harms
13:20
to
14:50
Auditorium I
Oral presentation session
Alcohol and other drug policies in the work setting – a perspective on European developments
13:20
to
14:50
Auditorium II
Oral presentation session
Young people and drugs
13:20
to
14:50
Auditorium III
Oral presentation session
Overdose prevention
13:20
to
14:50
Auditorium IV
Oral presentation session
Addressing diverse treatment needs
13:20
to
14:50
Auditorium VI
Oral presentation session
Substance use and mental health in prison settings
13:20
to
14:50
Auditorium VII
Oral presentation session
Regulating cannabis supply policies in Europe: navigating the long road to change
13:20
to
14:50
Auditorium VIII
Oral presentation session
Prevention and addiction in underrepresented groups
13:20
to
14:50
Room 5A
Oral presentation session
Impact of drug policy on drug production & markets
13:20
to
14:50
Room 5B
Oral presentation session